The results indicated a poor outcome in patients with non-small cell lung cancer who were negative for the most frequent HLA-A alleles, whereas patients expressing HLA-A*01 displayed prolonged progression-free survival and overall survival [34]. The gene discussed is HLA-A; the disease is non-small cell lung carcinoma.